Bemotrizinol sunscreens reach US store shelves after FDA approval

Bemotrizinol, a sunscreen ingredient used in Europe and elsewhere, is reaching U.S. store shelves after FDA approval in June, MedPage Today reported. The first products include formulas from Neutrogena and other manufacturers. MedPage said it is the first chemical-based sunscreen ingredient in the U.S. that protects against both UVA and UVB rays.

The FDA reviewed studies in more than 500 patients conducted by Dutch manufacturer DSM Nutritional Products. The studies found that levels absorbed into the skin were nearly undetectable. FDA reviewers said daily use for up to 3 weeks did not cause irritation or allergic reactions. The agency designated bemotrizinol generally recognized as safe and effective. The European Union’s environmental agency has found limited evidence of environmental toxicity, while longer-term research is still needed.